Eli Lilly is a top healthcare company that’s not only generating impressive growth right now, but continuing to invest in its future. American Express’ strong brand and clientele make it a resilient financial stock to invest in for the long haul.
Source: https://www.fool.com/investing/2026/01/15/3-unstoppable-stoc…
Procter & Gamble and Clorox offer reliable, well-covered dividends backed by strong fundamentals and long operating histories. PG faces near-term headwinds from high-interest rates and value-seeking consumers, but cost-saving initiatives and a solid balance sheet support continued dividend growth. CLX, despite recent declines in revenue and EPS, maintains a sustainable 4.5% yield and expects margin expansion and price appreciation as macro headwinds ease.
DraftKings’ bulls were thrown an unexpected curveball, but this new competition doesn’t carry the same brand-name cache. After years of development, Recursion Pharmaceuticals’ AI-powered drug discovery technology should finally, firmly start proving its true value.
ADEA and ACRE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 9th, 2026.
